Predictive Utility of Circulating Methylated DNA in Serum of Melanoma Patients Receiving Biochemotherapy

PURPOSE: Currently, no validated blood-based assays accurately predict treatment response or outcome in melanoma patients. We hypothesized that methylation of tumor-related genes detected in serum DNA could predict disease outcome and therapeutic response in patients receiving concurrent biochemothe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mori, Takuji, O’Day, Steven J., Umetani, Naoyuki, Martinez, Steve R., Kitago, Minoru, Koyanagi, Kazuo, Kuo, Christine, Takeshima, Teh-Ling, Milford, Robert, Wang, He-Jing, Vu, Vu D., Nguyen, Sandy L., Hoon, Dave S.B.
Format: Artigo
Idioma:Inglês
Publicat: 2005
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2856438/
https://ncbi.nlm.nih.gov/pubmed/16361635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2005.02.9876
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars